Enzon and Inex to Commercialize Oncology Drug
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 45 (Table of Contents)
Published: 4 Mar-2004
DOI: 10.3833/pdr.v2004.i45.822 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Inex Pharmaceuticals entered into a strategic partnership with Enzon Pharmaceuticals to develop and commercialize its flagship oncology product, Onco TCS, a liposomal anticancer vincristine formulation...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS